BTIG Research has recently resumed Blackstone Mortgage Trust Inc (BXMT) stock to Buy rating, as announced on July 19, 2024, according to Finviz. Earlier, on June 25, 2024, Wolfe Research had initiated ...

BTIG lowered the firm’s price target on Outlook Therapeutics (OTLK) to $9 from $50 and keeps a Buy rating on the shares. The ...

Tech was leading the way lower for stocks Wednesday. BTIG Chief Market Technician Jonathan Krinsky noted that while tech ...

Investors should start looking at restaurant names that have timely setups, said Jonathan Krinsky, chief market technician at ...

After adding nearly 30% in the previous session following its better-than-expected Q4 results for FY24, Embecta (NASDAQ:EMBC) ...

BTIG analyst Gray Powell raised the firm’s price target on Zscaler (ZS) to $238 from $205 and keeps a Buy rating on the shares. The firm’s ...

BTIG analyst Michael Gorman raised the firm’s price target on Agree Realty (ADC) to $78 from $74 and keeps a Buy rating on the shares. Agree ...

Pinstripes (NYSE:PNST – Free Report) had its target price lowered by BTIG Research from $4.00 to $3.00 in a report released on Wednesday, Marketbeat reports. The brokerage currently has a buy rating ...

Brinker stock is up 210% YTD versus 181% for Nvidia. BTIG recommends taking profits in EAT shares. It sees Darden stock as a ...

On Friday, Outlook Therapeutics Inc (OTLK) stock saw a modest uptick, ending the day at $1.97 which represents a slight increase of $0.27 or 15.88% from the prior close of $1.7. The stock opened at $1 ...

Agree Realty (NYSE:ADC – Free Report) had its price objective hoisted by BTIG Research from $74.00 to $78.00 in a report ...

Fintel reports that on November 27, 2024, BTIG upgraded their outlook for Embecta (NasdaqGS:EMBC) from Neutral to Buy. Analyst Price Forecast Suggests 20.45% Downside As of November 21, 2024, the ...